SpringWorks Therapeutics Inc (DELISTED) (SWTX:DL)
46.99
0.00 (0.00%)
USD |
NASDAQ |
Jul 07, 16:00
SpringWorks Therapeutics Profit Margin (Quarterly): -169.5% for March 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Vigil Neuroscience Inc (DELISTED) | -- |
| Merck & Co., Inc. | 33.68% |
| Cytokinetics, Inc. | -15.81K% |
| Vertex Pharmaceuticals, Inc. | 34.76% |
| Catheter Precision, Inc. | -1.04K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -49.69% |
| Return on Assets | -42.67% |
| Return on Invested Capital | -49.69% |
| Gross Profit Margin (Quarterly) | 92.81% |
| Operating Margin (Quarterly) | -164.1% |
| Return on Net Operating Assets | -365.9% |